JHOP Articles

Skip to main content

Breast Cancer, FDA Updates

FDA Approves First Hormonal-Based Therapy for Men with Advanced or Metastatic Breast Cancer

Yvette Florio Lane

Breast Cancer, FDA Updates

Proposed Landmark Policy Changes to Modernize Mammography and Raise Breast Density Awareness

Yvette Florio Lane

Lung Cancer, FDA Updates

FDA Approves Tecentriq plus Chemotherapy for First-Line Treatment of Extensive-Stage Small-Cell Lung Cancer

Yvette Florio Lane

Next-Generation Sequencing Testing in Oncology

Clinical Application of Next-Generation Sequencing in Oncology

Use of Next-Generation Sequencing in Oncology

FDA Updates

FDA Approves Tecentriq plus Abraxane—First Immunotherapy for PD-L1– Positive Unresectable Locally Advanced or Metastatic Triple-Negative Breast Cancer

Yvette Florio Lane

Review Article

Olanzapine for Prevention or Management of Chemotherapy-Induced Nausea and Vomiting: A Promising Option

Osama Al-Quteimat, MSc, BCOP, Jeffrey Tollison, RPh, BSPharm, BCPS, Mohammad Aslam Siddiqui, PharmD, MBA, CPHIMS

Osama Al-Quteimat, MSc, BCOP; Jeffrey Tollison, RPh, BSPharm, BCPS; Mohammad Aslam Siddiqui, PharmD, MBA, CPHIMS

Case Reports

Reactivation of Myasthenia Gravis Secondary to Nivolumab: Case Report and Literature Review

Amy Kamien, PharmD, BCOP, Ana Knuth, RPh, Cheruppolil Santhosh-Kumar, MD

Amy Kamien, PharmD, BCOP; Ana Knuth, RPh; Cheruppolil Santhosh-Kumar, MD

Original Research

Effectiveness of a Single 6-mg Fixed Dose of Rasburicase for Prevention or Management of Hyperuricemia Associated with Tumor Lysis Syndrome in Adults with Cancer

Mansoor Ahmed Khan, BS, MS, BCOP, Majed A. Alshamrani, PharmD, BCPS, BCOP, Mohammed A. Aseeri, PharmD, BCPS, FISMP, Ahmad S. Al Saeed, MD, Hani S. Alhamdan, BS, MS, Ahlam O. Masari, MD

Mansoor Ahmed Khan, BS, MS, BCOP; Majed A. Alshamrani, PharmD, BCPS, BCOP; Mohammed A. Aseeri, PharmD, BCPS, FISMP; Ahmad S. Al Saeed, MD; Hani S. Alhamdan, BS, MS; Ahlam O. Masari, MD

Page 154 of 199
Results 1531 - 1540 of 1986